GlassScriptPhysician profile
Jose A Monteiro
NPI 1548203219
$9,054.08
in general payments reported to CMS, 2019-2025
55 companies · $1,270 in 2025
The $1,270 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,448 · 2020: $864 · 2021: $1,299 · 2022: $1,168 · 2023: $1,714 · 2024: $1,291 · 2025: $1,270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,254 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,254.12 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,279.78 | 2019-2025 | Breztri, Farxiga, Fasenra |
| Pfizer INC. | $1,023.60 | 2019-2025 | |
| Abbvie INC. | $996.58 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $608.99 | 2020-2025 | |
| Novo Nordisk INC | $554.20 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $417.79 | 2020-2025 | Freestyle Libre 3 |
| Sunovion Pharmaceuticals INC. | $299.48 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.08 | 2019-2023 | Ofev |
| Amgen INC. | $290.71 | 2019-2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $254.77 | 2022-2025 | |
| Ardelyx, INC. | $231.47 | 2023-2025 | Ibsrela |
| Janssen Pharmaceuticals, INC | $216.76 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $195.76 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $195.02 | 2023-2025 | Camzyos, Eliquis |
| Mylan Specialty L.P. | $174.50 | 2019-2024 | Yupelri |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Monteiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.